These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8525290)
1. Evaluation of resistant-reversal, CDRI compound 87/209 and its possible mode of action in rodent experimental malaria. Srivastava R; Pandey VC; Bhaduri AP Trop Med Parasitol; 1995 Jun; 46(2):83-7. PubMed ID: 8525290 [TBL] [Abstract][Full Text] [Related]
2. A new class of potential chloroquine-resistance reversal agents for Plasmodia: syntheses and biological evaluation of 1-(3'-diethylaminopropyl)-3-(substituted phenylmethylene)pyrrolidines. Batra S; Srivastava P; Roy K; Pandey VC; Bhaduri AP J Med Chem; 2000 Sep; 43(18):3428-33. PubMed ID: 10978190 [TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605. Peters W; Robinson BL; Milhous WK Ann Trop Med Parasitol; 1993 Dec; 87(6):547-52. PubMed ID: 8122915 [TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines. Peters W; Stewart LB; Robinson BL Ann Trop Med Parasitol; 2003 Apr; 97(3):221-36. PubMed ID: 12803854 [TBL] [Abstract][Full Text] [Related]
5. Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains. Iwalokun BA Afr Health Sci; 2008 Mar; 8(1):25-35. PubMed ID: 19357729 [TBL] [Abstract][Full Text] [Related]
6. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice. Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815 [TBL] [Abstract][Full Text] [Related]
7. The chemotherapy of rodent malaria. LIX. Drug combinations to impede the selection of drug resistance, Part 3: Observations on cyproheptadine, an antihistaminic agent, with chloroquine. Peters W; Robinson BL; Stewart LB; Butcher GA Ann Trop Med Parasitol; 2000 Oct; 94(7):689-97. PubMed ID: 11144810 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine. Sahu R; Walker LA; Tekwani BL Malar J; 2014 Oct; 13():414. PubMed ID: 25336038 [TBL] [Abstract][Full Text] [Related]
9. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway. Safeukui I; Mangou F; Malvy D; Vincendeau P; Mossalayi D; Haumont G; Vatan R; Olliaro P; Millet P Biochem Pharmacol; 2004 Nov; 68(10):1903-10. PubMed ID: 15476661 [TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice. Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384 [TBL] [Abstract][Full Text] [Related]
11. Heme oxygenase and related indices in chloroquine-resistant and -sensitive strains of Plasmodium berghei. Srivastava P; Pandey VC Int J Parasitol; 1995 Sep; 25(9):1061-4. PubMed ID: 8847167 [TBL] [Abstract][Full Text] [Related]
12. Naringin and chloroquine combination mitigates chloroquine-resistant parasite-induced malaria pathogenesis by attenuating the inflammatory response. Bhatt D; Washimkar KR; Kumar S; Mugale MN; Pal A; Bawankule DU Phytomedicine; 2024 Oct; 133():155943. PubMed ID: 39154528 [TBL] [Abstract][Full Text] [Related]
13. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice. Siddiqi NJ; Alhomida AS In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052 [TBL] [Abstract][Full Text] [Related]
14. Antagonism of serum of mice infected with chloroquine-resistant 'NS' line to the antimalarial action of chloroquine. Li GD; Qian YL; Chen L Zhongguo Yao Li Xue Bao; 1989 May; 10(3):257-60. PubMed ID: 2692400 [TBL] [Abstract][Full Text] [Related]
15. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice. Tripathi R; Pandey SK; Rizvi A Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423 [TBL] [Abstract][Full Text] [Related]
16. Potential inhibitors of plasmodial heme oxygenase; an innovative approach for combating chloroquine resistant malaria. Srivastava P; Pandey VC; Misra AP; Gupta P; Raj K; Bhaduri AP Bioorg Med Chem; 1998 Feb; 6(2):181-7. PubMed ID: 9547941 [TBL] [Abstract][Full Text] [Related]
17. The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites. Fleck SL; Robinson BL; Peters W Ann Trop Med Parasitol; 1997 Jan; 91(1):33-9. PubMed ID: 9093427 [TBL] [Abstract][Full Text] [Related]
18. Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice. Hou LJ; Raju SS; Abdulah MS; Nor NM; Ravichandran M Jpn J Infect Dis; 2004 Oct; 57(5):198-202. PubMed ID: 15507775 [TBL] [Abstract][Full Text] [Related]
19. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice. Ishih A; Miyase T; Ohori K; Terada M Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234 [TBL] [Abstract][Full Text] [Related]
20. Poly ICLC enhances the antimalarial activity of chloroquine against multidrug-resistant Plasmodium yoelii nigeriensis in mice. Awasthi A; Mehrotra S; Bhakuni V; Dutta GP; Levy HB; Maheshwari RK J Interferon Cytokine Res; 1997 Jul; 17(7):419-23. PubMed ID: 9243375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]